Publications by authors named "Anne Ghys"

Claim this Profile
W
Week 96 resistance analyses of the once-daily, single-tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials.
Erkki Lathouwers, Shirley Weinsteiger, Bryan Baugh, Anne Ghys, John Jezorwski

J Med Virol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.
Erkki Lathouwers, Eric Y Wong, Kimberley Brown, Bryan Baugh, Anne Ghys

AIDS Res Hum Retroviruses· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.
Simone Susser, Mathieu Flinders, Henk W Reesink, Stefan Zeuzem, Glenn Lawyer, Anne Ghys

Antimicrob Agents Chemother· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region.
Christoph Sarrazin, Erkki Lathouwers, Monika Peeters, Bjorn Daems, Annemie Buelens, Anne Ghys

Antiviral Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay.
Christoph Sarrazin, Inge Dierynck, Gavin Cloherty, Anne Ghys, Katrien Janssen

J Clin Microbiol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-sequencing analysis of the gene encoding the hepatitis C virus nonstructural 3-4A protease confirms a low prevalence of telaprevir-resistant variants at baseline and the end of the REALIZE study.
Inge Dierynck, Kim Thys, Anne Ghys, James C Sullivan, Tara L Kieffer

J Infect Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling viral evolutionary dynamics after telaprevir-based treatment.
Eric L Haseltine, Sandra De Meyer, Inge Dierynck, Doug J Bartels, Anne Ghys

PLoS Comput Biol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir.
Sandra De Meyer, Anne Ghys, Inge Dierynck, Maria Beumont, Donghan Luo

Virol J· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection.
Gaston Picchio, Sandra De Meyer, Inge Dierynck, Anne Ghys, Linda Gritz

J Clin Virol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trial.
Yves Benhamou, Joseph Moussalli, Vlad Ratziu, Pascal Lebray, Katrien De Backer, Anne Ghys

J Infect Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials.
James C Sullivan, Sandra De Meyer, Doug J Bartels, Inge Dierynck, Eileen Z Zhang, Anne Ghys

Clin Infect Dis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials.
Tara L Kieffer, Sandra De Meyer, Doug J Bartels, James C Sullivan, Eileen Z Zhang, Anne Ghys

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: results from the REALIZE trial.
Sandra De Meyer, Inge Dierynck, Anne Ghys, Maria Beumont, Bjorn Daems

Hepatology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis